Login / Signup

Lipid emulsion therapy during management of the critically-ill poisoned patient: a prospective cohort study.

Michael LevineJeffrey BrentTimothy J WiegandBryan MaguireNeta CohenDavid VaerrierMichael BeuhlerJerrold B LeikinMichael GanetskySamuel J StellpflugAnne-Michelle RuhaJennifer CareyAnn-Jeannette GeibDazhe James CaoKurt KleinschmidtRais VohraBrad D RileyPhillip MooreEvan S SchwarzMark NeavynDaniel E RusyniakSpencer GreeneJoshua NogarAlex F ManiniMary WermuthAnthony F PizonRobert G HendricksonMatthew GriswoldKim AldyPaul WaxMeghan Beth SpyresSharan CamplemanErin MacdonaldYaron Finkelsteinnull null
Published in: Clinical toxicology (Philadelphia, Pa.) (2023)
Most patients in this cohort survived. Lipophilicity was not correlated with survival or the observed changes in blood pressure. The study did not address the efficacy of lipid emulsion.
Keyphrases
  • blood pressure
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • fatty acid
  • peritoneal dialysis
  • prognostic factors
  • type diabetes
  • stem cells
  • patient reported outcomes
  • skeletal muscle
  • blood glucose